MyFinsight
Home
Blog
About
Contact
Net decrease in cash
and cash...
-$4,386,850
Depreciation and
amortization
$956,401
Equity based
compensation
$451,381
Shares issued for
settlement of clinical...
$431,663
Common stock
contributed to 401 plan
$61,788
Share-based payments for
services
$57,106
Loss on patent
impairment
$22,257
Non-cash lease expense,
net of lease...
-$19,553
Proceeds from the
purchase of stock by...
$200,001
Net cash used in
operating activities
-$4,022,389
Net cash (used in)
provided by financing...
-$364,461
Canceled cashflow
$2,000,149
Canceled cashflow
$200,001
Net loss
-$5,465,751
Payments on obligations
under finance leases
$564,462
Due to employees
-$202,780
Prepaid expenses
$199,111
Accounts payable
-$101,031
Supplies used for r&d and
manufacturing
$26,905
Accrued expenses
-$26,240
Deposits
-$720
Back
Back
Cash Flow
CEL SCI CORP (CVM)
CEL SCI CORP (CVM)
source: myfinsight.com